Aurobindo Pharma

Ex-date alert! Aurobindo Pharma, 3 others to remain in spotlight next week

Notably, Indian equity markets will remain closed on Tuesday, April 14, on account of Dr Baba Saheb Ambedkar Jayanti.

Stocks to Watch today: Rate sensitives, Infosys, Aurobindo Pharma, GAIL

Stocks to Watch today, April 8, 2026: Banks, Real estate, automobiles, Infosys, Aurobindo Pharma are some of the key stocks to watch today

Stocks to Watch today: Godrej Consumer, Aurobindo Pharma, IRFC, PC Jeweller

Stocks to Watch today, April 7, 2025: Godrej Consumer, Aurobindo Pharma, IRFC, ACME Solar Holdings, PC Jeweller, and Titagarh Rail are some of the key stocks to watch today

Aurobindo Pharma sets April 12 as record date for ₹800 crore buyback

Company to repurchase up to 54.24 lakh shares at Rs 1,475 apiece through tender offer route, with promoters also eligible to participate in the buyback

Aurobindo up 4%; stock hits 52-week high, outperforms in 2026; here's why

Aurobindo Pharma to evaluate and consider a proposal for the buyback company's fully paid-up equity shares in its board meet on April 6.

Granules, Aurobindo Pharma among top stocks to buy today; check targets

Kunal Kamble, senior technical research analyst at Bonanza, has recommended buying shares of Aurobindo Pharma, Granules India, and Wheels India today

Aurobindo gains 3%, stock hits 52-week high; JM Financial sees more upside

In the past one month, Aurobindo has outperformed the market by surging 9 per cent, as compared to 8.5 per cent decline in the BSE Sensex.

Trading guide: Check key Nifty levels to watch; two stocks to buy today

According to Vinay Rajani of HDFC Securities, the stock price of Aurobindo Pharma has broken out from the bullish flag pattern on the daily chart

Bharti Airtel, Aurobindo Pharma are top stock picks for today; here's why

Stocks to buy today: Bharti Airtel, and Aurobindo Pharma are the top stock picks by Rajesh Bhosale of Angel One

Stocks to Watch today: Tata Steel, Tech Mahindra, Varun Bev, Shree Cement

Stocks to Watch today, March 18: Tata Steel, Tech Mahindra, Varun Beverages, Shree Cement, and Aurobindo Pharma are among the top stocks to watch today

Stocks to Watch today: ACME Solar, Gravita India, Kalpataru, Raymond Realty

Stocks to Watch today, March 13: Aurobindo Pharma, Godrej Properties, KPI Green Energy, JK Lakshmi Cement, Max Financial Services, and Nectar Lifesciences are among the top stocks to remain in focus

Nifty, Bank Nifty outlook; Aurobindo Pharma, ABB among top stock picks

Bank Nifty has to hold above 56,750 zones for a bounce towards 57,250 then 57,500 levels while a hold below the same could see some weakness towards 56,500 then 56,250 zones

Aurobindo arm launches Pomalidomide generic in US, adds to oncology line

Aurobindo Pharma subsidiary Eugia Pharma has launched generic Pomalidomide Capsules in the US, one of the first-to-file applicants for the drug, expanding its oncology portfolio

Aurobindo Pharma shares rise 4% after incorporating Engenra Biologics arm

The newly formed entity will operate in the pharmaceuticals sector and has been set up to expand the company's contract manufacturing and other pharmaceutical manufacturing operations

Expect Pen-G production capacity to touch 10k MT in 12 months: Aurobindo

Aurobindo Pharma is looking to ramp up the production of Penicillin-G to over 10,000 metric tonnes on an annual basis over the next 12 months, according to company CFO S Subramanian. The Hyderabad-based drug maker also expects its China-based manufacturing plant to break even in EBITDA in Q4 and meaningfully contribute to the bottom-line EBITDA in the next year. "The ramp-up of the facility (Pen-G) is progressing in line with expectations and is well-positioned to deliver a meaningful uplift in profitability over time. Based on our current production level, we expect to produce more than 10,000 metric tonnes on an annualised basis over the next 12 months," Subramanian told analysts in a call. The company's Pen-G facility, located in a SEZ at Kakinada in Andhra Pradesh, is expected to touch production capacity of 15,000 metric tonnes per annum over a period of time. "It is important to note that the yield levels are steady and improving consistently over time," Subramanian said. Th

Axis Sec sees upside in pharma, hospitals; Lupin, Aurobindo among top bets

Axis Securities has named Lupin, Aurobindo Pharma, Max, and Fortis as top picks, citing strong fundamentals, resilient growth drivers, and robust operational execution

Aurobindo Pharma up 3% in weak market, rebounds 6% from Wednesday's low

Aurobindo's management maintains confidence in achieving an internal EBITDA margin target of 20-21 per cent for FY26, supported by strong operating leverage and a diversified business model.

Voda Idea, DLF, RBL Bank among 18 F&O stocks to attract 15% higher margin

The NSE to levy 15% additional margin on equity derivatives in which top 10 clients account for more than 20% MWPL from March F&O series onwards; withdraws additional margin on Gold, Silver futures.

Aurobindo Pharma shares drop 5% amid reports of USFDA observations

According to media reports, the USFDA inspected its Unit-7 facility from January 28 to February 10, 2026, and issued observations at the end of the inspection

Aurobindo Pharma sinks 8%, stock hits over 3-month low post Q3 results

Aurobindo Pharma stock outlook: Eugia III resolution (in the backdrop of fresh observations) and the launch momentum across geographies would be key determinants, say analysts.